Eventide Asset Management’s Immunogen Inc IMGN Stock Holding History

Eventide Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-763,000	Closed	-$22.6M	–	176
2023 Q4	$22.6M	Sell	763,000 -537,000	-41%	-$10.7M	0.37%	80
2023 Q3	$20.6M	Hold	1,300,000	–	–	0.37%	80
2023 Q2	$24.5M	Buy	+1,300,000	New	+$15.3M	0.41%	73
2022 Q2	–	Sell	-1,000,000	Closed	-$4.76M	–	148
2022 Q1	$4.76M	Hold	1,000,000	–	–	0.07%	121
2021 Q4	$7.42M	Buy	+1,000,000	New	+$6.21M	0.09%	119

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eventide Asset Management's IMGN Position: Q1 2024 in Review

Eventide Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 763,000 shares — an estimated $22.6M sold.

Eventide Asset Management first reported a position in IMGN in Q4 2021 and held it in 5 quarters. The position peaked at $24.5M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Eventide Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Eventide Asset Management sold 763,000 Immunogen Inc shares in Q1 2024, an estimated $22.6M.
Eventide Asset Management first reported a position in Immunogen Inc in Q4 2021 and held it in 5 quarters.
Eventide Asset Management's Immunogen Inc position peaked at $24.5M in Q2 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.